page

Search

1 2 3211 212 213 214 215527
Showing 21212130 of 5261 Items
NutraHempCBD Announces March Promo is for You, and Your Pet Too
March 08, 2019

NutraHempCBD Announces March Promo is for You, and Your Pet Too

Page
NutraHempCBD celebrates St. Patrick’s Day with 40% off a 600mg Full Spectrum Tincture and a Pet Wellness Tincture combo!Coconut Creek, FL - (NewMediaWire) - March 8, 2019 - NutraHempCBD, a line of hemp-derived cannabidiol (CBD) products from the life sciences company, Nutralife Biosciences, Inc. (Nutralife or “the Company”) is celebrating St. Patrick’s Day by offering 40% off when you buy a 600mg Full Spectrum Tincture and a Pet Wellness Tincture! The promo price will be $80, that’s reduced from the original $135 sticker price.NutraHempCBD full spectrum cannabidiol formula has 600 mg of hemp-derived CBD in every bottle and has been hailed by consumers as a convenient way to reap the benefits of full-spectrum cannabidiol. This NutraHempCBD formula comes in an easy-to-dose spray instead of an oily dropper and customers can expect delivery of 14 mg of full-spectrum hemp-derived CBD per six-spray serving. The hemp utilized is grown on a USDA Certified Organic farm and the formula is flavored with stevia leaf extract for a superior taste.The NutraPet Drops are for your furry friends! Our pet CBD products are designed to provide anti-inflammatory and overall wellness factors. Our pet-friendly formula comes in convenient CBD drops that can be added directly to your pet’s favorite food or treat. The drops deliver 8.33 mg hemp-derived full spectrum CBD per serving and just like our human spray the CBD is from hemp grown on an organic farm.NutraLife Biosciences, Inc., formerly known as NutraFuels, Inc., (“NutraLife” or the “Company”) also recently announced a name change to NutraLife BioSciences, Inc. and new stock trading symbol, NLBS. The Company believes that the name, NutraLife BioSciences better reflects its current and planned future operations.The Company is a fully reporting company with a class of securities registered with the U.S. Securities and Exchange Commission (“SEC”). The Company recently announced its financial results for the three (3) and nine (9) month period ended September 30, 2018 with revenue of $1,062,146 and $2,870,462 respectively compared to $652,385 and $1,027,727 for the three (3) and nine (9) month period ended September 30, 2017. NTFU’s filings with the SEC can be viewed at www.sec.gov. NTFU’s CBD products and information about the company’s direct sales program can be found online atwww.nutrahempcbd.com and by following the company on Instagram.* These statements have not been evaluated by the Food and Drug Administration.* This product is not intended to diagnose, treat, cure or prevent any disease.Forward-Looking StatementsThis communication contains statements of a forward-looking nature. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. You can identify these forward-looking statements by words or phrases such as “may,” “will,” “except,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “future” or other similar expressions. The Company has based these forward-looking statements largely on the Company’s current expectations and projections about future events and financial trends that the Company believes may affect Company’s financial condition, results of operations, business strategy, and financial needs. There is no assurance that the Company’s current expectations and projections are accurate. All forward-looking statements in this press release are based on information available to the Company on the date hereof. These statements involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results to differ materially from those implied by the forward-looking statements. More detailed information about these risk factors are set forth in the Company’s filings with the Securities and Exchange Commission, including, but not limited to, those risks and uncertainties listed in the section entitled “Risk Factors,” in the Company’s Annual Report on Form 10-K with the Securities and Exchange Commission on April 17, 2018. The Company operates in a ...
March 08, 2019

Tauriga Sciences Inc. to Produce Additional Tauri-Gum(TM) Inventory Due to Stronger than Expected Indications of Demand

Page
New York, NY - (NewMediaWire) - March 8, 2019 - Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced that it has placed an order with its manufacturer for the production of additional Tauri-Gum™ inventory at this time. The Company believes that this decision is prudent, due to stronger than expected initial indications of demand from a broad array of prospective distributors and customers. On March 7, 2019, the Company placed an order with its manufacturer for an additional 8,700 individual packs; delivery to the Company (for this 2ndinventory tranche) is expected during mid-April 2019. The Company continues to realize significant progress on a number of different initiatives and is excited for its upcoming commercial launch (later this month) of its CBD infused chewing gum product line, branded as Tauri-Gum™. In other news, the Company continues to be in productive discussions with Amazon and is hopeful that Tauri-Gum™ will be approved for listing, in the near term.ABOUT: TAURIGA SCIENCES, INC.Tauriga Sciences, Inc. (TAUG) is engaged in building business through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities. One such opportunity on which the Company has acted, involves the Company having entered into the cannabidiol (or “CBD”) infused chewing gum product business, as more fully described above and in prior press releases. This CBD infused chewing gum product has been branded under the following name: Tauri-GumTM. See also our periodic reports filed by us with the SEC for a more complete description of our business and material agreements that we have entered into. Further, the Company continues to identify and evaluate additional potential opportunities to generate revenue, as well as shareholder value, and leverage its resources and expertise to build a diversified and sustainable business model. Please visit our corporate website at www.tauriga.com. In addition, the Company is currently constructing an E-Commerce site for the sale of its CBD Infused Chewing Gum. This site is being constructed under the following URL address: www.taurigum.comForward-Looking StatementsThis press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not ...
March 08, 2019

CBD Life Sciences Subsidiary LBC Bioscience Launches CBD Based Anti-Aging Product Line

Page
Scottsdale, AZ - (NewMediaWire) - March 08, 2019 - CBD Life Sciences Inc. (OTC: CBDL) is pleased to announce that its wholly owned subsidiary, LBC Bioscience, Inc., has now finalized the formulization for and is launching an organic - GMO free - CBD based anti-aging product line. The product line includes: anti-aging day serum, CBD based eye gel, nourishing face serum with retinol, blemish balancing serum, CBD vitamin C face serum, and CBD based face cream. The Global Anti-Aging Market was worth $42.51 Billion in 2018 and estimated to $55.03 Billion by 2023. LBC Bioscience, Inc. is positioning itself to be a leader in CBD based anti-aging and is already in talks with a number of companies to ‘white label’ the product line. In addition, LBC Bioscience, Inc. is working with Dr. Farhan Taghizadeh of Arizona Facial Plastics P.C. to develop a case study showing the effectiveness of the product line. Arizona Facial Plastics is a leading cosmetic surgery based in Phoenix, Arizona. About CBD Life Sciences Inc.CBD Life Sciences Inc. is a publicly traded company having its common shares quoted on the OTC Markets under the symbol ‘OCSYD’. The Company’s main focus is to identify, evaluate and acquire undervalued opportunities with the objective of increasing shareholder value. The acquisition of LBC Bioscience Inc. is the first in the CBD space and the company is actively searching for additional opportunities within this emerging sector.About LBC Bioscience Inc. LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC is developing and marketing a line of cannabidiol based organic products such as hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions, supplements, edibles, and a full line of pet products. In addition, LBC is in the process of developing an anti-aging skin product line. LBC’s products can be viewed and purchased on the company’s website at www.lbcbioscienceinc.com.Contact InformationInvestor RelationsTen Associates LLC11529 N. 120th St.Scottsdale, Arizona85259 USATelephone: 480-326-8577Thomas E. NelsonEmail: tenassociates33@gmail.comForward-Looking StatementsExcept for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See Optium Cyber Systems, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.Safe Harbor StatementThis release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
March 08, 2019

NexTech Raises $1,464,600 From $0.50 Warrant Conversion

Page
New York NY - (NewMediaWire) - March 08, 2019 - NexTech AR Solutions (the “Company” or “NexTech”) (OTC: NEXCF) (CSE: NTAR) (FSE: N29), a technology and emerging commercial growth company focused on bringing augmented reality (“AR”) to the masses through its web-enabled AR platform for eCommerce, announced today that further to the Company’s press release dated February 5, 2019, the previously announced warrant call ended on March 7, 2019 and the $0.50 warrants dated March 29, 2018 are no longer exercisable.● 2,929,200 warrants were exercised during the 30 day acceleration period for proceeds totaling $1,464,600.● The Company has 54,049,372 common shares issued and outstanding. ● 5,502,100 warrants expired on March 7, 2019.● Cash position is now $3,500,000The Company is actively looking for additional acquisitions and continuing to develop its new business pipeline, targeting high-growth verticals such as eCommerce, Education & Training, and Live Streaming & Telepresence, with an initial focus on the global retail eCommerce market, projected to reach $4.8 trillion in 2021, according to Statistica. Recent research has shown that 40% of online shoppers would be willing to pay more for a product if they could experience it through AR, while 71% of shoppers indicated they would shop at a brand more often if it offered AR experiences.About NexTech AR Solutions Corp.NexTech is bringing a next generation web enabled augmented reality (AR) platform with Artificial Intelligence (AI) and analytics to the Cannabis industry, eCommerce, education, training, healthcare and video conferencing. Having integrated with Shopify, Magento and Wordpress its technology offers eCommerce sites a universal 3D shopping solution. With just a few lines of embed code, the company’s patent-pending platform offers the most technologically advanced 3D-AR, AI technology anywhere. Online retailers can subscribe to NexTech’s state of the art, 3D-AR/AI solution for $79/mo. The company has created the AR industry’s first end-to-end affordable, intelligent, frictionless, scalable platform.For further information, please contact:Evan GappelbergChief Executive Officerinfo@nextechar.com Media contact:Erin HaddenFischTank Marketing and PRehadden@fischtankpr.comThe CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.Certain information contained herein may constitute “forward-looking information” under Canadian securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as, “will be”, “looking forward” or variations of such words and phrases or statements that certain actions, events or results “will” occur. Forward-looking statements regarding the Company increasing investors awareness are based on the Company’s estimates and are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of NexTech to be materially different from those expressed or implied by such forward-looking statements or forward-looking information, including capital expenditures and other costs. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. NexTech will not update any forward-looking statements or forward-looking information that are incorporated by reference herein, except as required by applicable securities laws.
Hookah smokers are inhaling toxic chemicals that may harm the heart
March 08, 2019

Hookah smokers are inhaling toxic chemicals that may harm the heart

Page
Statement Highlights: Smoking tobacco in hookahs results in inhaling significant levels of toxic chemicals, such as carbon monoxide, and particulates from tobacco that can harm blood vessels and the heart. Globally, hookah smoking is more common among youth and young adults, encouraged by flavored tobacco marketing, social media promotion and misperceptions regarding its addictive potential and health effects. Embargoed until 4 a.m. CT / 5 a.m. ET Friday, March 8, 2019 (NewMediaWire) - March 08, 2019 - DALLAS - Smoking tobacco in waterpipes, more commonly known as hookahs, results in inhaling toxic chemicals, often at levels exceeding cigarette smoke, that may harm the heart and blood vessels, according to a new scientific statement published in the American Heart Association’s journal Circulation. Waterpipes go by many names - hookah, narghile, argileh, shisha and goza – and usually consist of a head or bowl that holds tobacco, a body, water base and hose that ends with a mouthpiece. Burning charcoal is placed on top of the tobacco-filled bowl. Hookah tobacco is usually a combination of dried fruit, flavored tobacco and substances to keep the tobacco moist. During a hookah smoking session that typically last for 30 or more minutes, users inhale many liters of smoke filled with large quantities of particulate matter at higher concentrations than cigarettes. Although direct comparisons between hookahs and cigarettes have some limitations, a single session of hookah use typically results in greater exposure to carbon monoxide than a single cigarette. Even short-term exposure to carbon monoxide in hookahs is toxic and can interfere with exercise capacity, according to the statement authors. In addition to carbon monoxide, hookah smoke contains other potentially harmful chemicals that can affect the cardiovascular system, including nicotine, air pollutants, particulate matter, volatile organic chemicals, polycyclic aromatic hydrocarbons, acrolein, lead, cadmium and arsenic. Most of these toxins are higher in hookah than cigarette smoke. “Hookah smoke contains harmful substances and the American Heart Association strongly recommends avoiding the use of tobacco in any form,” said Aruni Bhatnagar, Ph.D., chair of the writing group for the statement and professor of medicine and director of the University of Louisville Diabetes and Obesity Center in Kentucky. There is growing evidence that hookah tobacco smoking acutely impacts heart rate and blood pressure. Chronic use is associated with increased coronary artery disease risk. “Many young people mistakenly believe that smoking tobacco from a hookah is less harmful than cigarette smoking because the tobacco if filtered through water, but there is no scientific evidence that supports that claim. However, there is evidence to suggest that hookah smoking is addictive and can lead to the use of other tobacco products such as cigarettes,” said Bhatnagar. The spread of hookah smoking, especially among young people, is promoted by several factors, including sweetened and flavored hookah tobacco, social media that promotes this method of tobacco use and misperceptions regarding its addictive potential and adverse health effects. Unlike cigarette tobacco, hookah tobacco, often colorfully packaged, can be sold in candy and fruit flavors, which appeal to younger audiences. The flavors and sweeteners added to the tobacco mask the harshness of smoke, making it easier to start and continue smoking hookahs. In addition, because many people smoke hookah in lounges and cafes it is perceived to be a social activity and less habit-forming. More importantly, most of the tobacco marketed to hookah users does not carry a health warning, leading to the misperception that it is not harmful. In the United States, recent surveys have estimated hookah usage that range from 4. 8 percent among high school students to 13.6 percent of young adults (18-24 years old). People 18-24 years of age also accounted for 55 percent of hookah smokers nationwide. In addition, those who use a hookah are more likely ...
March 07, 2019

Weyland Tech Inc. Announces Updates Coinciding With Investor Conference Call

Page
New York, March 07, 2019 (NewMediaWire) -- Weyland Tech Inc. (WEYL) (“Weyland” or the “Company”) announces updates coinciding with an investor conference call held on March 7, 2019 at 12 noon EST.In addition to updates on the Company’s core PaaS business and its eWallet, AtozPay, the following major initiatives and objectives are underway and in various stages:Expression of Interest for acquisition of the AtozPay business by a large regional tech companyUpdate on outstanding litigation in Singapore and US Federal court in NevadaPotential for merger and expansion into new emerging marketQualification for NASDAQ and re-engagement of applicationPotential for acquisition of the AtozPay business by a large regional tech companyAs announced on September 6, 2018, there has been an increase in private fundings, IPOs and merger and acquisition activity leading to the emergence of large ‘unicorn’ companies competing for marketshare in SE Asia. In February, the Company received an expression of interest in the acquisition of its eWallet business from a regional leader in ride-sharing and delivery. Comparable valuation metrics make this a source of encouragement as we follow through on our mandate at Weyland to build, grow, and sell the businesses that we launch in emerging markets.Our team in Indonesia continues to build the platform making it attractive to potential acquirers and the landscape continues to improve for a sale.Potential for merger and expansion into new emerging marketManagement has identified and begun an initiative for entry into our second emerging market in SE Asia. During this process the possibility of a merger with a larger group possessing country licensing and infrastructure needed for rapid expansion has been raised. There have been numerous meetings, calls and terms proposed and should there be a firm agreement, we will pursue it with our Board of Directors and subsequently inform shareholders.Update on outstanding litigation in Singapore and US Federal court in NevadaRegarding the current litigation in Singapore and in the US Federal Court in Nevada, over the past two months there has been substantial progress and we remain optimistic that a settlement favorable to shareholders is imminent. Qualification for NASDAQ and re-engagement of applicationThe management team has moved forward re-opening our NASDAQ application and, based upon meetings and discussions with NASDAQ, the Company currently qualifies under most of the criteria for a NASDAQ listing. As we progress, we will inform shareholders.About Weyland Tech Inc.Weyland Tech is a global provider of mobile business applications. The Company operates a Platform-as-a-Service (“PaaS”) software used on mobile ‘smartphones’. The PaaS platform offers a mobile presence to Small-to-Medium-Sized- Businesses (“SMB’s”) in emerging markets, with partnerships on 3 continents and growing. The PaaS platform, offered in 14 languages with over 70 integrated modules, enables SMB’s to create native mobile applications (“apps”) for Apple’s iOS and Google Android without technical knowledge or background, empowering SMB’s to increase sales, reach more customers and promote their products and services in an easy, affordable and efficient manner.About WIP/AtoZPayWeyland Indonesia Perkasa (“WIP”) / AtoZPay is an Indonesian Company that is held by Weyland Tech via both equity and contractual structures which comply with Indonesia’s foreign commercial ownership regulations. AtoZPay, an eWallet solution, is quickly becoming the adopted standard in Indonesia, the world’s 4th most populous nation, with a majority of consumers without bank accounts. A partnership with Finnet, Indonesia’s state-controlled company tasked with building and supporting banking and finance infrastructure nationwide, and a recently achieved banking license, creates the most robust solution for the “unbanked” in Indonesia. Weyland Tech owns 100% the eWallet software platform which powers AtozPay. In a liquidity event or outright exit via an acquisition, Weyland and its sub-holding (WAI) are entitled ...
1 2 3211 212 213 214 215527
Showing 21212130 of 5261 Items